Physician-supervised GLP-1, dual incretin, and adjunctive metabolic therapies — individualized to your biomarkers and titration plan.
Physician-supervised GLP-1, dual incretin, and adjunctive metabolic therapies — individualized to your biomarkers and titration plan.
Our weight management program combines clinically validated therapies with support for energy, nausea management, and metabolic optimization.
Semaglutide is a GLP-1 receptor agonist and offers advanced therapy that help regulate appetite, blood sugar, and metabolism.
Semaglutide is a GLP-1 receptor agonist and offers advanced therapy that help regulate appetite, blood sugar, and metabolism. Available in 5 subcutaneous concentrations. injectable form comes with your choiceof B12 or glycine combinations. Also, available is sublingual form (under-the-tongue).
Compounded semaglutide combined with B12 to support energy during weight management.
This formulation combines compounded semaglutide — the same GLP-1 receptor agonist used as a standalone — with vitamin B12 in a single weekly injection. B12 is added to support energy metabolism and to address suboptimal B12 status, which can worsen the fatigue some patients experience during GLP-1 titration.
Compounded semaglutide formulated with glycine for stability and tolerability.
This formulation combines compounded semaglutide with glycine — a small amino acid used in compounded formulations to support solution stability and pH buffering. Glycine has independent research interest in sleep, glucose handling, and protein synthesis.
Tirzepatide is a GIP/GLP-1 receptor agonist and offers advanced therapy that help regulate appetite, blood sugar, and metabolism.
Tirzepatide is a GIP/GLP-1 receptor agonist and offers advanced therapy that help regulate appetite, blood sugar, and metabolism. This is why dual therapies often works better then GLP-1 alone. Available in 6 subcutaneous concentrations. injectable form comes with your chocie of B12 or glycine combinations. Also, available is sublingual form (under-the-tongue).
Compounded tirzepatide combined with B12 to support energy during weight management.
This formulation pairs compounded tirzepatide — the dual GIP/GLP-1 receptor agonist — with vitamin B12 in a single weekly injection. B12 is added to support energy metabolism and address suboptimal levels that can worsen titration-phase fatigue.
Compounded tirzepatide formulated with glycine for stability and tolerability.
This formulation combines compounded tirzepatide with glycine — used in compounded formulations for solution stability and pH buffering. It is the standard alternative for patients who don't tolerate or don't want B12 in their weekly injection.
A lipotropic injection that supports fat metabolism, liver function, and energy.
Lipo-B is a injection used to support fat metabolism and weight loss. It contains a powerful combination of Methionine, Inositol, and Choline (with added Vitamin B12). These ingredients help your body break down and remove fat from the liver, boost energy levels, and improve how efficiently your body uses fat for fuel.
Provider review considers the full clinical picture before any recommendation is made.
Conditions, prior diagnoses, allergies, and relevant contraindications.
Potential interactions, duplicate therapies, and safety concerns.
Symptoms, priorities, tolerance, and practical preferences.
Baseline and follow-up labs are considered when they change clinical decisions.
Lumora is not a checkout flow. A licensed provider reviews fit and safety before treatment.
Share goals, history, and relevant symptoms. No card required.
A licensed provider evaluates eligibility, safety factors, and fit.
If appropriate, the provider shares a plan and pricing before you commit.
Treatment can be adjusted, paused, or stopped based on response and safety.
Explore whether weight management & metabolic health care is a fit. A provider reviews your assessment before treatment is recommended.
